September 9, 2020 Comments Off on Patent delisted for Abbvie drug KALETRA Posted in: Uncategorized
Annual Drug Patent Expirations for KALETRA Kaletra is a drug marketed by Abbvie and is included in three NDAs. It is available from three suppliers. KALETRA drug price trends. Drug…
The post Patent delisted for Abbvie drug KALETRA appeared first on Dru…
September 9, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Posted in: Uncategorized
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fifteen…
The post Patent delisted for Boehringer Ingelheim drug TRIJARDY XR a…
